John Kozarich
Chairman bei LIGAND PHARMACEUTICALS INCORPORATED
Vermögen: 3 Mio $ am 31.03.2024
Profil
John W.
Kozarich is currently the Chief Executive Officer & Director at Nucorion Pharmaceuticals, Inc. He is also the Chief Executive Officer & Director at Curza Global LLC since 2019.
Previously, he served as the Chairman at Ligand Pharmaceuticals, Inc. starting from 2003.
He was also a Director at Merck Research Laboratories Massachusetts LLC.
In addition, he holds positions as an Adjunct Professor at The Scripps Research Institute and the University of Texas at Austin.
Dr. Kozarich has held former positions as the Chief Executive Officer & Director at QLT, Inc. in 2013, Chairman, President & Chief Science Officer at ActivX Biosciences, Inc. from 2014 to 2017, and Chairman at Intec Pharma Ltd.
from 2016 to 2021.
He has also served as a Director at Poxel SA, Adaptive Therapeutics, Inc., Novelion Therapeutics, Inc., Retrophin, Inc., and Alkermes, Inc. Furthermore, he was an Independent Non-Executive Director at Corium International, Inc. from 2007 to 2015 and an Independent Director at Travere Therapeutics, Inc. from 2015 to 2020.
Dr. Kozarich has a doctorate degree from the Massachusetts Institute of Technology and an undergraduate degree from Boston College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 24.04.2024 | 42 523 ( 0,24% ) | 3 Mio $ | 31.03.2024 |
Aktive Positionen von John Kozarich
| Unternehmen | Position | Beginn |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Chairman | 01.03.2003 |
Nucorion Pharmaceuticals, Inc.
 Nucorion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nucorion Pharmaceuticals, Inc. develops pharmaceutical products. The company is headquartered in San Diego, CA. | Chief Executive Officer | - |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | - |
Curza Global LLC
 Curza Global LLC Pharmaceuticals: MajorHealth Technology Curza Global LLC engages in operation of a small-molecule therapeutics firm. It develops several structurally distinct classes of proprietary drugs focused on infectious diseases and oncology. The company is headquartered in Salt Lake City, UT. | Chief Executive Officer | 01.11.2019 |
| Gordon Research Conferences | Director/Board Member | - |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Director/Board Member | - |
| University of Texas at Austin | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von John Kozarich
| Unternehmen | Position | Ende |
|---|---|---|
Intec Pharma Ltd.
 Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of drugs based on proprietary Accordion Pill platform technology. Its Accordion Pill technology is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs under development by utilizing an efficient gastric retention and specific release mechanism. The company was founded by Zvika Joseph on October 23, 2000 and is headquartered in Jerusalem, Israel. | Chairman | 21.06.2021 |
| TRAVERE THERAPEUTICS, INC. | Director/Board Member | 01.01.2020 |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - |
Ausbildung von John Kozarich
| Massachusetts Institute of Technology | Doctorate Degree |
| Boston College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| POXEL | Health Technology |
| TRAVERE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 11 |
|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
ActivX Biosciences, Inc.
 ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology ActivX Biosciences, Inc. develops pharmaceutical products. It discovers and develops small molecule drugs for major unmet medical needs. The company was founded in 2000 and is located in La Jolla, CA | Health Technology |
Adaptive Therapeutics, Inc.
 Adaptive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adaptive Therapeutics, Inc. develops pharmaceutical products. It develops drugs for applications in anti-bacterial, fungal, viral, and cancer therapeutics. The company was founded in 2002 and is headquartered in San Diego, CA | Health Technology |
Corium International, Inc.
 Corium International, Inc. Pharmaceuticals: MajorHealth Technology Corium International, Inc. is a pharmaceutical company. It offers products such as corplex donepezil and memantine. The company was founded by Gary W. Cleary and Adrian L. Faasse, Jr. in 1999 and is headquartered in Menlo Park, CA. | Health Technology |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
| Gordon Research Conferences | |
Intec Pharma Ltd.
Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of drugs based on proprietary Accordion Pill platform technology. Its Accordion Pill technology is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs under development by utilizing an efficient gastric retention and specific release mechanism. The company was founded by Zvika Joseph on October 23, 2000 and is headquartered in Jerusalem, Israel. | Health Technology |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada. | Health Technology |
Nucorion Pharmaceuticals, Inc.
Nucorion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nucorion Pharmaceuticals, Inc. develops pharmaceutical products. The company is headquartered in San Diego, CA. | Health Technology |
Curza Global LLC
Curza Global LLC Pharmaceuticals: MajorHealth Technology Curza Global LLC engages in operation of a small-molecule therapeutics firm. It develops several structurally distinct classes of proprietary drugs focused on infectious diseases and oncology. The company is headquartered in Salt Lake City, UT. | Health Technology |
